186 related articles for article (PubMed ID: 29265023)
1. Clinical & immunological characteristics in systemic lupus erythematosus patients.
Rastin M; Mahmoudi M; Sahebari M; Tabasi N
Indian J Med Res; 2017 Aug; 146(2):224-229. PubMed ID: 29265023
[TBL] [Abstract][Full Text] [Related]
2. Anti-RO/SSA and anti-La/SSB antibodies: Association with mild lupus manifestations in 645 childhood-onset systemic lupus erythematosus.
Novak GV; Marques M; Balbi V; Gormezano NW; Kozu K; Sakamoto AP; Pereira RM; Terreri MT; Magalhães CS; Guariento A; Sallum AM; Marini R; Ferriani VP; Barbosa CM; de Castro TC; Ramos VC; Bonfá E; Silva CA
Autoimmun Rev; 2017 Feb; 16(2):132-135. PubMed ID: 27988434
[TBL] [Abstract][Full Text] [Related]
3. Early Lupus Project - A multicentre Italian study on systemic lupus erythematosus of recent onset.
Sebastiani GD; Prevete I; Piga M; Iuliano A; Bettio S; Bortoluzzi A; Coladonato L; Tani C; Spinelli FR; Fineschi I; Mathieu A
Lupus; 2015 Oct; 24(12):1276-82. PubMed ID: 25979916
[TBL] [Abstract][Full Text] [Related]
4. Evaluating Anti-SmD1-amino-acid 83-119 Peptide Reactivity in Children with Systemic Lupus Erythematosus and Other Immunological Diseases.
Yang HO; Zhang XQ; Fu QH
Chin Med J (Engl); 2016 Dec; 129(23):2840-2844. PubMed ID: 27900999
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
Yang Z; Ren Y; Liu D; Lin F; Liang Y
APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and outcome of southern Chinese males with systemic lupus erythematosus.
Mok CC; Lau CS; Chan TM; Wong RW
Lupus; 1999; 8(3):188-96. PubMed ID: 10342711
[TBL] [Abstract][Full Text] [Related]
7. Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patients.
Vlachoyiannopoulos PG; Karassa FB; Karakostas KX; Drosos AA; Moutsopoulos HM
Lupus; 1993 Oct; 2(5):303-12. PubMed ID: 8305923
[TBL] [Abstract][Full Text] [Related]
8. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus.
Carreño L; López-Longo FJ; Monteagudo I; Rodríguez-Mahou M; Bascones M; González CM; Saint-Cyr C; Lapointe N
Lupus; 1999; 8(4):287-92. PubMed ID: 10413207
[TBL] [Abstract][Full Text] [Related]
9. Anti-Ro/SSA antibodies are associated with severe mitral valve regurgitation in patients with systemic lupus erythematosus.
Higuera-Ortiz V; Mora-Arias T; Castillo-Martinez D; Amezcua-Guerra LM
Mod Rheumatol; 2017 May; 27(3):476-480. PubMed ID: 27425425
[TBL] [Abstract][Full Text] [Related]
10. Survival impact of autoantibodies in systemic lupus erythematosus.
Gulko PS; Reveille JD; Koopman WJ; Burgard SL; Bartolucci AA; Alarcón GS
J Rheumatol; 1994 Feb; 21(2):224-8. PubMed ID: 8182629
[TBL] [Abstract][Full Text] [Related]
11. Rare autoantibodies to cellular antigens in systemic lupus erythematosus.
Fredi M; Cavazzana I; Quinzanini M; Taraborelli M; Cartella S; Tincani A; Franceschini F
Lupus; 2014 Jun; 23(7):672-7. PubMed ID: 24557777
[TBL] [Abstract][Full Text] [Related]
12. [Serological and histological study of lupus nephritis with special reference to anti-SSA antibody].
Nakashima A
Nihon Jinzo Gakkai Shi; 1989 Jul; 31(7):743-55. PubMed ID: 2585828
[TBL] [Abstract][Full Text] [Related]
13. Immunological and Clinical Characteristics of Systemic Lupus Erythematosus: A Series from Morocco.
Zian Z; Maamar M; Aouni ME; Barakat A; Naima Ghailani Nourouti ; El Aouad R; Arji N; Bennani Mechita M
Biomed Res Int; 2018; 2018():3139404. PubMed ID: 30363993
[TBL] [Abstract][Full Text] [Related]
14. Perinuclear anti-neutrophil cytoplasmic antibody in systemic lupus erythematosus indicates more severe condition.
Pan Y; He L
Clin Biochem; 2021 Mar; 89():38-43. PubMed ID: 33307059
[TBL] [Abstract][Full Text] [Related]
15. Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations.
Vilá LM; Alarcón GS; McGwin G; Friedman AW; Baethge BA; Bastian HM; Fessler BJ; Reveille JD;
Rheumatology (Oxford); 2004 Mar; 43(3):358-63. PubMed ID: 14623949
[TBL] [Abstract][Full Text] [Related]
16. Chilblain lupus erythematosus is associated with antibodies to SSA/Ro.
Franceschini F; Calzavara-Pinton P; Quinzanini M; Cavazzana I; Bettoni L; Zane C; Facchetti F; Airò P; McCauliffe DP; Cattaneo R
Lupus; 1999; 8(3):215-9. PubMed ID: 10342714
[TBL] [Abstract][Full Text] [Related]
17. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus.
Hanly JG; Thompson K; McCurdy G; Fougere L; Theriault C; Wilton K
J Immunol Methods; 2010 Jan; 352(1-2):147-52. PubMed ID: 19836394
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH
Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384
[TBL] [Abstract][Full Text] [Related]
19. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody.
Saigal R; Goyal LK; Agrawal A; Mehta A; Mittal P; Yadav RN; Meena PD; Wadhvani D
J Assoc Physicians India; 2013 Jun; 61(6):372-7. PubMed ID: 24640201
[TBL] [Abstract][Full Text] [Related]
20. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
Meyer O
Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
